When it comes to metabolic health and blood sugar regulation, antioxidants play a far more active role than just fighting free radicals. One of the most clinically significant antioxidants in this space is Alpha-Lipoic Acid (ALA) — a compound that supports both glucose metabolism and nerve function at the cellular level.

Core Control includes 150 mg of ALA per serving — a dose that aligns with emerging research on oxidative stress reduction, insulin sensitivity, and neuroprotection, particularly when used daily in a multi-ingredient formula.

What Is Alpha-Lipoic Acid?

Alpha-Lipoic Acid is a naturally occurring fat- and water-soluble antioxidant made in small amounts by the human body. Unlike most antioxidants, ALA works in both cellular membranes and cytoplasm, giving it a broad range of activity.

It functions as a:

• Cofactor in mitochondrial energy production

• Scavenger of free radicals

• Regenerator of other antioxidants (like vitamin C and E)

• Insulin-mimetic compound, helping glucose enter cells

Because of its dual solubility, ALA plays a central role in energy metabolism, nerve protection, and inflammation modulation.

What Does the Research Say?

Most high-dose clinical trials use 300 to 600 mg of ALA per day, often in people with type 2 diabetes or peripheral neuropathy. However, lower doses (150 mg/day) have still demonstrated meaningful effects in combination formulas and longer-term usage.

• A 2012 study in Diabetes & Metabolic Syndrome found that just 150 mg/day of ALA improved markers of oxidative stress and glucose metabolism when taken alongside other micronutrients.

• In trials on metabolic syndrome, even modest ALA dosing (100–200 mg) improved fasting glucose and endothelial function over 4 to 12 weeks.

• ALA has also shown promise in reducing the symptoms of diabetic neuropathy, particularly burning, tingling, and nerve pain, by protecting nerve cells from oxidative damage.

Why 150 mg Works in Synergy

In Core Control, the 150 mg dose of ALA is part of a synergistic matrix that includes:

• Berberine, which activates AMPK (just like ALA)

• Chromium, which enhances insulin signaling

• Magnesium, critical for glucose transport and nerve signaling

• BioPerine®, which may enhance ALA’s absorption and stability

This design allows for lower but effective dosing — maximizing the benefits of ALA while avoiding the digestive sensitivity sometimes reported at higher levels.

Who Can Benefit from ALA?

ALA supplementation is ideal for people who are:

• Concerned about insulin resistance or metabolic syndrome

• Experiencing early nerve discomfort or glucose-related tingling

• Focused on cellular energy, oxidative stress, and aging defense

• Looking for broad metabolic support without overstimulation

ALA’s unique ability to cross the blood-brain barrier also makes it valuable in cognitive support and neuroinflammation research.

The Bottom Line

While alpha-lipoic acid is often associated with high-dose therapy in clinical settings, its daily use at 150 mg in combination with other metabolic compounds is both evidence-informed and practical. In Core Control, ALA helps create a foundation for improved glucose handling, nerve health, and cellular balance.

If you’re looking for a nutrient that bridges blood sugar support, antioxidant defense, and neurological health, ALA belongs on your radar — and in your regimen.